Summary.-Oestrogen (RE) and progesterone (RP) cytosolic receptors have been studied in 59 clinically inflammatory tumours of the human breast. The results were compared to those obtained in a series of 496 operable tumours. A single saturating dose of oestradiol for RE and R 5020 for RP was used and the cut-off between negative and positive tumours was 100 fmol/g tissue. A significant difference was seen (P < 0.02) between the 2 classes of patients: (RE-, RP-) tumours were commoner among clinically inflammatory tumours (48%) than among operable ones (28%), independently of menopause. Concerning the histological type (based on an assessment of differentiation) and the histological grading (Scarff and Bloom) there was a significant difference (P<0-001) between the 2 populations of tumours. No significant difference was found in the distribution of RE and RP among the 3 histological types, whereas a significant correlation existed between histological grading and RE (P <0-02).
ently of menopause. Concerning the histological type (based on an assessment of differentiation) and the histological grading (Scarff and Bloom) there was a significant difference (P<0-001) between the 2 populations of tumours. No significant difference was found in the distribution of RE and RP among the 3 histological types, whereas a significant correlation existed between histological grading and RE (P <0-02).
Finally, patients with RE+ clinically inflammatory tumours constitute a lower risk group, especially when they are free of metastases at the time of diagnosis. The presence of RE therefore seems to indicate, as in the operable tumour group, a favourable prognosis.
THE clinically inflammatory tumours are considered to be very severe carcinomas, reflecting serious imbalance in the tumour-host relationship (Denoix, 1970) . They are of unfavourable prognosis and are characterized by a particularly low rate of survival at 5 years (-150%) (Fletcher & Montague, 1975; Lacour & Hourtoule, 1967) . These tumours very seldom show any of the microscopic features typical of clinically characterized "inflammation" (Haagensen, 1971) .
In the present study, we have simultaneously determined oestrogen receptors (RE) and progesterone receptors (RP) in inflammatory tumours of the human breast, and have compared these results with those obtained in primary operable carcinomas. The prognostic value of RE has been studied as well, since the presence of RE should be a favourable prognostic factor, independently of other known factors in primary operable carcinomas (Knight et al., 1977; Fletcher et al., 1978; Cooke et al., 1979) .
MATERIALS AND METHODS
Patients.-The present series includes 59 female patients with clinically inflammatory tumours of the breast. Diagnosis and treatment were performed at the Institut GustaveRoussy between March 1975 and December 1977. Metastatic work-up included chest X-rays, mammograms, X-rays of the pelvis, and bone or liver scans. Inflammatory tumours are defined as tumours associated with local inflammatory symptoms (cutaneous oedema, skin redness and heat). These signs are either localized in a part of or are in the whole breast. The rapidly growing tumours (identi-fied by careful history taking) were not included in this study.
We Radiotherapy was given in two steps: a first step between the 3rd and the 4th cycle (45 Gy to the breast, chest wall and regional lymph nodes over 41 weeks) and a second step between the 4th and 5th cycle (20 Gy to the breast over 2 weeks).
Hormone therapy was adapted to the hormonal status of the patient: castration by pelvic irradiation in the premenopausal women with lymph-node involvement and Tamoxifen in the others.
Receptor assay.-Immediately after large biopsy under local anaesthesia, tumour specimens (100-200 mg) were transported to the laboratory on ice within a few minutes of operation. Malignancy was verified by histological examination by the pathologist. The samples were crushed at 00C in 3 volumes of buffer (0O01M Tris-HCl, 0-012M dithiotreitol, 10% glycerol, pH 7.4) with an ultraturrax (3-4 five-second bursts with 15-second cooling intervals) and homogenized in a Teflon-glass homogenizer.
The homogenate was centrifuged for 1 h at 105,000 g in the 50 Ti rotor of a Beckman L2 centrifuge. The supernatant (= cytosol) was used to determine RE and RP with a singlesaturating-dose method previously described (May-Levin et al., 1977) . Tumours with levels of specific-binding sites greater than 100 fmol/g tissue were RE+, RP +. This cut-off was arbitrarily chosen, and corresponds to the limit of sensitivity of our technique ; it is comparable to those chosen by several authors (Horwitz et al., 1975; Wittliff et al., 1976 Miscellaneous.-We have also determined: (a) Histological types, which were divided into 3 classes (Scarff & Torloni, 1968; : "well-differentiated" (tubular or papillary); "pleomorphic" (infiltrating ductal carcinoma with 2 components mixed: tubular and trabecular); "atypical" (infiltrating ductal carcinoma without tubular or papillary components).
Our series had only one medullary adenocarcinoma with lymphoplasmocytic stroma.
(b) Histological grading according to WHO and Scarff and Bloom (Bloom, 1950; Bloom & Richardson, 1957) taking into consideration: the degree of differentiation; nuclear pleomorphism; mitotic activity.
(c) Tumour cell density (see above). Labelled steroids (oestradiol for RE, R 5020 for RP) were purchased from New England Nuclear Corp. (6072 Dreieich, W. Germany).
Statistical significance between groups was determined by the x2 test and adjustment test of Boyd & Doll (1954) . Disease-free survival rates were calculated by the Kaplan-Meier method (1958) and curves compared by the log-rank test (Peto et al., 1976 (Peto et al., , 1977 .
RESULTS
Histological characteristics and hormone receptors Pre-and post-menopausal cases had the same distribution of all histological characteristics, allowing us to combine the 2 populations for our study.
There was a significant difference (P < 0-001) between operable and inflammatory tumours in terms of histological type (Table I) . Operable tumours were more often pleomorphic, inflammatory tumours more often atypical. On the other hand, no significant difference was found in the distribution of RE among the 3 histological types, either for operable tumours or for inflammatory ones (Table  II) .
There was a significant difference (Table III) .
A significant correlation was found We have tried to determine whether RE (P < 0-02) between histological grading status influenced the evolution of the and RE for inflammatory tumours only, disease. This has been done by studying as shown in Table IV . Grade III are more the disease-free curves of RE+ and REfrequently RE-and Grade II more patients (Kaplan & Meier, 1958) . For infrequently RE+; there was no tumour in flammatory tumours, Fig. 1 (140) 48% (28) 18% (91) 19% (11) 15% (76) 5% (3) 38% (189) 28% (17) P<0-02.
the curves, however, show more favourable evolution for patients with RE+ tumours (P < 0 01). If we exclude patients with metastases at diagnosis, we obtain a more significant difference (log-rank, (P < 0 001) between the disease-free curves of patients with RE+ and RE-tumours (Fig. 2) . Concerning the operable tumours, the prognostic value of RE is under study; Haagensen, 1971 ) who found that the atypical type accounted for 80% of 59 cases. As opposed to our results, Martin et al. (1978) found a relationship between histological type and RE distribution, on the basis of classification into 2 categories: well-differentiated and pleomorphic with more than 50% differentiation, and atypical and pleomorphic with less than 50% differentiation.
As for the histological grading of Scarff and Bloom, as has already been observed (Sarrazin et al., 1978) we find these inflammatory tumours to be highly malignant with 70% being classified as Grade III, the most unfavourable group. While a significant relationship between histological grading and RE distribution could be shown only for the inflammatory tumours, such a relationship (though not statistically significant) was also seen for the operable tumours. Our results are identical to those reported by other groups (Maynard et al., 1978; Furmanski et al., 1980; King, 1980; McCarty et al., 1980; Millis, 1980) . Taken together, these results confirm that RE and RP receptors represent an aspect of cell differentiation of tumours. Furthermore, other authors (Meyer et al., 1977; Silvestrini et al., 1979) have shown that tumours with a high growth rate and labelling index are most frequently without receptors.
The fact that inflammatory tumours show a higher proportion of RE-, RPcases than the operable tumours is a further argument for distinguishing between the 2 tumour types May-Levin et al., 1977) . Our results thus indicate that, amidst this population of inflammatory tumours with a generally poor prognosis, there is a histo-biological subgroup with a still worse prognosis.
The clinical progression seems to confirm these observations. The prognostic value of RE for the inflammatory tumours is in keeping with results published for the operable tumours (Knight et al., 1977; Fletcher et al., 1978; Cooke et al., 1979; Furmanski et al., 1980; Osborne et al., 1980) even if sometimes (Blamey et al., 1980 ) the prognostic value is limited to the N+ tumours. Only Hilf et al. (1980a,b) found no favourable prognostic index for the operable RE+ tumours. Nevertheless, we must point out that patients in our study were all subjected to the same systemic treatment; it is thus possible that the efficiency of the hormonal treatment is at least partially responsible for the favourable evolution of RE+ tumours, which should be hormone sensitive.
Finally, we consider it interesting that the frequency of RE+ tumours is the same in the pre-menopausal (46%) and the postmenopausal (48%) groups. A study carried out in parallel with ours at the Institute Gustave-Roussy (Rouesse et al., 1979 ) for comparison of current treatment modalities (chemotherapy and hormone therapy) for inflammatory tumours with the previous surgical approaches, has shown that only pre-menopausal women benefit from this approach (both in terms of survival rate and duration of remission). However, RE assay could not be carried out in all patients, so that no correlation could here be drawn.
